<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="112322">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01641055</url>
  </required_header>
  <id_info>
    <org_study_id>2011/572</org_study_id>
    <nct_id>NCT01641055</nct_id>
  </id_info>
  <brief_title>A Study of the Effects of Fish Protein Intake on Glucose Homeostasis and Inflammation in Overweight and Obese Adults.</brief_title>
  <official_title>A 8 wk Study to Compare the Effects of Proteins and Peptides From Various Fish Species (Salmon, Herring, Cod) on Glucose Homeostasis and Inflammatory Markers in Overweight and Obese Adults.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bergen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BlueProtein</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NutriMar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Bergen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the possible health benefits of intake of proteins
      and peptides (small proteins) from salmon, herring and cod on glucose tolerance and
      inflammatory markers in overweight and obese adults. Overweight and obese subjects often
      have reduced glucose tolerance and a chronic low-grade inflammation, and previous findings
      from a study on cod proteins suggested that both glucose tolerance and immune function were
      improved.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants receive 5g protein or peptide per day for 8 weeks as tablets.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose tolerance</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inflammatory status</measure>
    <time_frame>Two years</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">94</enrollment>
  <condition>Obesity</condition>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>Salmon peptide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Herring peptide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Cod protein</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Milk protein</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Salmon peptide</intervention_name>
    <description>5g salmon peptide per day for 8wk.</description>
    <arm_group_label>Salmon peptide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Herring peptide</intervention_name>
    <description>5g herring peptide per day for 8wk.</description>
    <arm_group_label>Herring peptide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cod protein</intervention_name>
    <description>5g cod protein per day for 8wk.</description>
    <arm_group_label>Cod protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Milk protein</intervention_name>
    <description>5g milk protein per day for 8wk.</description>
    <arm_group_label>Milk protein</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI above 28

          -  healthy

        Exclusion Criteria:

          -  fasting blood glucose above 7 mM

          -  medication that affects blood glucose, lipids and inflammatory status

          -  smoking
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oddrun A Gudbrandsen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bergen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Medicine, University of Bergen</name>
      <address>
        <city>Bergen</city>
        <zip>5021</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 19, 2013</lastchanged_date>
  <firstreceived_date>July 12, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Bergen</investigator_affiliation>
    <investigator_full_name>Oddrun Anita Gudbrandsen</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
